openPR Logo
Press release

Acute Ischemic Stroke Diagnosis And Treatment Market Key Players Abbott Laboratories, Covidien plc, Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare

01-22-2019 09:23 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Market Data Forecast

Acute Ischemic Stroke Diagnosis And Treatment Market

Acute Ischemic Stroke Diagnosis And Treatment Market

Acute Ischemic Stroke Diagnosis and Treatment market Overview

The Acute Ischemic stroke can be defined as loss of function in certain parts of the brain due to lack of blood supply to the brain.

 Request for Sample @ https://www.marketdataforecast.com/market-reports/acute-ischemic-stroke-diagnosis-market-265/request-sample

Drivers

Increase in incidence of ischemic stroke
Increase in number of diabetes, hypertension, lipid disorders, obesity and tobacco use
Quick growth in geriatric population
Restraints

Shortage of reimbursement policies
Shortage of skilled professionals
 Acute Ischemic Stroke Diagnosis and Treatment market Forecast Report (2018-2023)

Global Acute Ischemic Stroke Treatment and Diagnosis Market worth was $2203.59 million in 2018 and estimated to be growing at a CAGR of 6.7%, to reach $3047.56 million by 2023.

 Browse Report Brief and TOC @   https://www.marketdataforecast.com/market-reports/acute-ischemic-stroke-diagnosis-market-265/

Acute Ischemic Stroke Diagnosis and Treatment market Segmentation

Global Acute Ischemic Stroke Diagnosis and Treatment Market is classified into Diagnostic type and Surgery type.  On the basis of the Diagnostic type, the market is further sub-classified into Computed Tomography, Ultrasound, Magnetic Resonance Imaging, Cerebral angiography, and nuclear imaging. Based on Surgery Type the market is divided into Carotid Endarterectomy, Angioplasty, and Endovascular Mechanical Thrombectomy. Carotid Endarterectomy is the main segment accounting for a share of approximately XX% and is expected to maintain its strong share owing to highest success rate, short treatment duration, and easy availability.

On the Basis of geography global Acute Ischemic Stroke Diagnosis and Treatment Market is classified into North America, Europe, Asia-Pacific, Latin America, and Africa & Middle-East. North America is the large market for Acute Ischemic Stroke Diagnosis and Treatment devices accounting for a share of approximately 30% in 2018 and is approximated to continue its stronghold of the market owing to favourable government initiatives, technological innovations and rising demand for ischemic stroke products. Asia-Pacific is estimated to be a hopeful market for the acute ischemic stroke diagnosis owing to increasing incidence of ischemic stroke cases in the region. Manufacturers are increasing their operations in the Asia-Pacific region as these regions hold immense potential for the market growth.

KEY MARKET BENEFITS:

Complete analysis of factors that drive and restrict the growth of the global acute ischemic stroke diagnosis and treatment market is provided.
The report provides a comprehensive analysis of the market and estimations through 2018-2023, which would enable the stakeholders to capitalize on prevailing current market opportunities.
An in-depth analysis of the prime segments of the market demonstrate the types of therapeutics along with the diagnostics that currently used in the acute ischemic stroke market.
SWOT analysis highlights the internal environment of major leading companies for effective strategy formulation.
The acute ischemic stroke diagnosis and treatment market scenario is comprehensively analysed in accordance to the prime regions
Competitive intelligence highlights the business practises followed by leading current market players across geographies.
 Major Players: 

Some of the major players In Acute Ischemic Stroke Diagnosis and Treatment market are

Abbott Laboratories,
Covidien plc, Philips Healthcare,
Johnson & Johnson,
Penumbra, Inc.,
GE Healthcare,
Siemens Healthcare,
Stryker Corporation (Concentric Medical, Inc.)
Hitachi, Ltd.

Buy now @   https://www.marketdataforecast.com/cart/buy-now/acute-ischemic-stroke-diagnosis-market-265/
 

Customize Report @ https://www.marketdataforecast.com/market-reports/acute-ischemic-stroke-diagnosis-market-265/customize-report

About Us

Market Data Forecast is determined working in the areas of market research, business intelligence and consulting. We have a great experience in research and consulting for various business domains to cater the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast

Email: abhishek@marketdataforecast.com  

Tel: +1-888-702-9626

Website: www.marketdataforecast.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Ischemic Stroke Diagnosis And Treatment Market Key Players Abbott Laboratories, Covidien plc, Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare here

News-ID: 1514970 • Views:

More Releases from Market Data Forecast

Business Management Consulting Service Market is expected to witness a significant growth rate
Business Management Consulting Service Market is expected to witness a significa …
According to the latest research report published by Market Data Forecast, the global business management consulting services market is estimated to grow at a CAGR of 4.3% from 2024 to 2029 and be worth USD 1148 bn by 2029 from USD 930.15 bn in 2024. The demand for consulting services is fuelled by the need for outside help from several enterprises, charitable organizations, and government agencies. Business management consulting advises organizations
Antimicrobial Coatings Market expected to witness a significant growth rate of 11% by 2029.
Antimicrobial Coatings Market expected to witness a significant growth rate of 1 …
According to the latest research report published by Market Data Forecast, the global antimicrobial coatings market is expected to grow at a CAGR of 11% during the forecast period 2024-2029. The market value was at USD 5 billion in 2023 and the value is expected to reach USD 9 billion by the end of 2029. It is applied to stop microorganisms and other bacteria from growing and expanding. These are extensively
End-User Computing Market Sees Explosive Growth Globally
End-User Computing Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the global end-user computing market is predicted to reach USD 15.33 billion in 2024 and USD 27.99 billion in 2029, growing at a CAGR of 12.8% during the forecast period. Today's workforce is moving, with employees looking to access corporate data, apps, and online resources across more devices and locations. While supporting workplace mobility, minimizing risk, and maintaining compliance, end-user
Smart Homes Market Size, Share, Growth Report 2024-2029
Smart Homes Market Size, Share, Growth Report 2024-2029
According to the latest research report published by Market Data Forecast, the global smart home market is predicted to reach USD 114.92 billion in 2024 and USD 221.46 billion by 2029, growing at a CAGR of 14.02% during the forecast period. Advancements in IoT technology, as well as rising consumer demand for convenience and energy efficiency, are driving significant growth in the smart home industry. Smart thermostats, lighting, security systems, and

All 5 Releases


More Releases for Acute

Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth